Back to MORGAN STANLEY MORGAN STANLEY

GNTAGNTA
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in GENENTA SCIENCE S P A

No. Morgan Stanley exited its GNTA (Genenta Science) position in Q2 2026. Its Q1 2026 13F listed 15,420 shares worth $10,361. Morgan Stanley already held GNTA in its Q2 2024 13F, the earliest on record, and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2,135

Total Shares Change

-500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$1.84
0
2026-Q1
Decreased
15,420
-66.4%
$10,3610.0%$0.67
0
2025-Q4
Increased
45,900
+1986.4%
$68,3910.0%$1.49
23
2025-Q3
Increased
2,200
+10.0%
$6,9960.0%$3.18
12
2025-Q2
Decreased
2,000
-41.2%
$6,0900.0%$3.05
0
2025-Q1
New
3,400
-
$13,4980.0%$3.97
27
2024-Q4
Exited
0
-100.0%
$00.0%$4.35
0
2024-Q3
Unchanged
500
0.0%
$2,1350.0%$4.27
0

Other major holders of GNTA: Bank Julius Baer & Co. Ltd, Zurich, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used